ArticleInternational journal of molecular sciences2022

Synergistic Anti-Angiogenic Effect of Combined VEGFR Kinase Inhibitors, Lenvatinib, and Regorafenib: A Therapeutic Potential for Breast Cancer.

Khuloud Bajbouj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.